Last Price | 2.10 | Max Price | 7.40 |
Min Price | 1.30 | 1 Year return | -74.33 |
Sector | Industry | Subsector | Support Services |
Year | Turnover | Total sector | Market share |
---|---|---|---|
2019 | 91 | 665,529 | 0.01 % |
2020 | 79 | 640,773 | 0.01 % |
2021 | 131 | 697,909 | 0.02 % |
2022 | 128 | 798,307 | 0.02 % |
2023 | 0 | 0 | 0.00 % |
No Records Found
No Records Found
No Records Found
Pacific Biosciences of California's core business is the biotech sector. The period from 2006 till the end of 2016 the international sector gained around 59 percent. As from 2011 the sector is 70 percent higher and over the past 12 months (December 2015-December 2016) there is a minus of 59 percent.
Over the last 12 months (from December 2015 till December 2016), that were loss-making period for the investors in Pacific Biosciences of California, the stock lost around 64 percent. The period between August 2011 and August 2016 was a profitable period for the investors. The stock rose on average 77 percent. Pacific Biosciences of California's revenues between 2011 and 2015 were very volatile through the time and moved between 25,98 million dollars and 92,78 million dollars. Pacific Biosciences of California's net incomes between 2011 and 2015 were very volatile and moved between -109,39 million dollars and -31,7 million dollars.
The American company didn't pay out any dividends (in the past 5 years).
At the end of 2015 the biotech company's balance sheet was worth 131,11 million dollars. Last year the total debt of the company was 57,57 million dollars. This equals around 43,91 percent of the total balance sheet. As per the end of 2015 Pacific Biosciences of California's price/earnings-ratio equaled -19. So investors paid for 1 stock -19 times the earnings per share of 2015. We could say that based on her price/earnings-ratio and dividend yield the American stock can be seen as a value stock.
At the end of 2015 the American company's market capitalization equaled around 955,76 million dollars. At the end of 2015 the American company had around 75,61 million stocks listed.
On this page you can find all Pacific Biosciences of California's financial reports. More information about Pacific Biosciences of California can be found it's website. .
Results |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Revenue |
93
|
91
|
93
|
79
|
91
|
79
|
Costs |
124
|
165
|
186
|
181
|
175
|
49
|
Profit |
-32
|
-74
|
-92
|
-103
|
-84
|
29
|
Margin of profit |
-34.17
|
-82.00
|
-98.63
|
-130.43
|
-92.56
|
37.27
|
ROI |
-43.11
|
-87.85
|
-107.07
|
-89.92
|
-153.19
|
8.76
|
Balance |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Equity |
74
|
85
|
86
|
114
|
55
|
335
|
Debt |
58
|
53
|
58
|
56
|
93
|
78
|
Total assets |
131
|
138
|
144
|
170
|
148
|
414
|
Solvency |
56.09
|
61.41
|
59.76
|
66.98
|
37.11
|
81.04
|
Cash |
82
|
72
|
63
|
102
|
49
|
319
|
Cashflow |
-48
|
-68
|
-68
|
-66
|
-78
|
20
|
Employees |
0
|
0
|
0
|
0
|
0
|
|
Revenue per employee |
0.0
|
0.0
|
0.0
|
0.0
|
0.0
|
|
Cashflow / Debt |
-0.83
|
-1.28
|
-1.16
|
-1.18
|
-0.84
|
0.25
|
Details |
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|
Price |
13.13
|
3.80
|
2.64
|
7.40
|
5.14
|
Eps |
-0.83
|
-0.87
|
-0.76
|
-0.55
|
0.17
|
Price/earnings-ratio |
-15.82
|
-4.37
|
-3.47
|
-13.45
|
12.35
|
Dividend |
0.0
|
0.0
|
0.0
|
0.0
|
|
Dividend % |
0.00 %
|
0.00 %
|
0.00 %
|
0.00 %
|
|
Payout % |
0.0
|
0.0
|
0.0
|
0.0
|
|
Book value |
0.91
|
0.74
|
0.76
|
0.36
|
1.74
|
Market to book |
0.07
|
0.19
|
0.29
|
0.05
|
0.83
|
Cashflow per stock |
-0.73
|
-0.58
|
-0.44
|
-0.51
|
0.10
|
Stocks |
93
|
116
|
150
|
153
|
192
|
Market Cap |
1.216.85
|
441.85
|
396.64
|
1.133.08
|
403.82
|
Date
|
Price
|
---|---|
09 Jan 2025
|
2.10
|
17 Dec 2024
|
2.05
|
10 Dec 2024
|
2.18
|
06 Dec 2024
|
1.98
|
03 Dec 2024
|
1.93
|
29 Nov 2024
|
1.76
|
27 Nov 2024
|
1.77
|
13 Nov 2024
|
2.21
|
08 Nov 2024
|
2.45
|
05 Nov 2024
|
2.51
|
31 Oct 2024
|
2.16
|
29 Oct 2024
|
1.84
|
23 Oct 2024
|
1.80
|
19 Oct 2024
|
1.98
|
16 Oct 2024
|
2.10
|
14 Oct 2024
|
1.98
|
05 Oct 2024
|
1.72
|
02 Oct 2024
|
1.62
|
27 Sep 2024
|
1.74
|
20 Sep 2024
|
2.04
|
17 Sep 2024
|
1.85
|
13 Sep 2024
|
1.80
|
28 Aug 2024
|
1.47
|
26 Aug 2024
|
1.56
|
23 Aug 2024
|
1.44
|
11 Aug 2024
|
1.59
|
07 Aug 2024
|
1.60
|
05 Aug 2024
|
1.67
|
01 Aug 2024
|
2.06
|
30 Jul 2024
|
2.05
|